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INTRODUCTION
Cleft lip with or without cleft palate (CLP) is a
common congenital disability. They exist either in
combination with one or more other anomalies
(syndromic cleft) or in isolation (non-syndromic cleft).
Non-syndromic CL/P is more common as it is present
in about 70% of cases, out of which 80% are sporadic,
and 20% are familial.1 CLP which is commoner in
males, occurs in 1 out of 300 to 2500 births, while
isolated cleft palate (CP) which occurs more frequently
in females, occurs in 1 out of 1500 births2.3. People
with cleft lip and palate often require multidisciplinary
care involving several surgical repairs commencing in
the first year of  life, orthodontic interventions for
malocclusion, speech therapy, treatment of  recurrent
middle ear infections, and psychological interventions.
These have been noted to contribute a significant
burden to the patient, family, and society at large. Thus,
an intense effort has been made to unravel its aetiology,
which would be important in genetic counselling, risk
prediction, and overall prevention of cleft lip and
palate4.
Aetiology of Cleft Lip and Palate
Generally, cleft lip and palate is thought to result from
interactions between genetic and environmental factors.
Substantial pieces of  evidence for the former have
arisen from family, and twin studies which revealed
high rates of  familial aggregation and increased
concordance rates in monozygous twins, compared
with dizygous twins5. For instance, studies by Sivertsen
et al.6 and Grosen et al.7 showed that cleft palate has a
relative risk of occurrence which is 15 to 56 times
higher among first degree relatives. Although
environmental factors such as maternal use of alcohol,
cigarette and antiepileptic drugs have been identified
as risk factors for CLP, recent studies have now
revealed important genes either acting alone or within
gene networks. Such cases are found as parts of
Mendelian monogenic syndromes, chromosomal
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abnormalities, or otherwise unknown genetic
syndromes8. These identified genetic risk factors have
shed more light on normal craniofacial development
with some also implicated in non-syndromic CL/P.
As an example of gene-environment interaction, Shaw
et al.9 demonstrated a 3 to 8 fold increase in CLP in
babies with lack of multivitamins in the first trimester
of  pregnancy and the TaqI C2 mutation in the Tgfa
gene. The same mutation was shown to raise the risk
of CLP by 6 to 8 times when co-existent with maternal
smoking10, while Jugessur et al.11 found that combined
mutations of the Tgfa and Msx1 genes cause an almost
ten-fold increase in cleft lip and palate risk as an
evidence of gene-gene interaction.
Genetic Regulation of Craniofacial Development
Craniofacial development is a complex event involving
several transcription factors and molecular signals.
Disruptions in the network of these proteins lead to
the development of  facial clefts. The diversity in the
functions of these genes and their products shows the
susceptibility of the craniofacial developmental
pathways to form clefts4.
Facial development in humans begins in the fourth
week of intrauterine life with the migration of cranial
neural crest cells (CNC) from the rostral part of the
neural tube to form the facial primordia and secondary
palate8. Genes such as Tgfb2, Hoxa2, Gli2, and Gli3
have been identified to play a role in CNC migration,
mutations of which have been shown to contribute
to cleft lip and palate in mice12-14. Palatal shelves are
subsequently derived from the secondary palate and
undergo elevation to become horizontally apposed in
the midline. Failure of apposition has been linked with
mutations in the genes Msx1, Pax9and Lhx8 leading
to CP15-17. Furthermore, epithelial-mesenchymal
interactions mediated by interrelated gene networks –
sonic hedgehog (Shh), bone morphogenetic proteins
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AR Pvrl1 11q23.3 Encodes nectin-1 which plays a




















AD Tp63 3q28 Apoptosis. Also in establishment
of enhancers needed for expression
of genes important in craniofacial
development such as Irf6
Yes 32-24
Roberts syndrome AR Esco2 8p21 Acetyltransferase activity necessary
for sister chromatid cohesion
needed for cell proliferation
- 35,36
Hay-Wells syndrome AD Tp63 3q28 As for RHS Yes 37
Blepharocheilodontic
syndrome
AD Cdh1 16q22 Cell adhesion molecule involved in









AD Yap1 11q22 Activation of transcription factors









AD Meis2 15q14 Palatal fusion. Repression of
SHH/FGF feedback loop.
- 45,46





AD Tp63 3q28 As for RHS Yes 48
Branchiooculofacial
syndrome (BOFS)
AD Tfap2a 6p24 Transcription activation necessary






X-linked Tbx22 Xq21 Repressor of transcription, with an
important role in horizontal
elevation of palatal shelves
- 52,53





AD Specc1l 22q11.23 Regulates microtubule and actin




















Regulation of SHH signaling - 62-64
Waardenburg
syndrome, type 1
AD Pax3 2q36 Transcription factor necessary for
skeletal muscle formation
- 65,66
CHARGE syndrome AD Chd7 8q12 Transcription factor necessary for
neural crest cell migration
67,68
DiGeorge syndrome AD Tbx1 22q11.21 Regulator of BMP signaling - 69
Table1: Summary of  molecular genetic mechanisms in syndromic cleft lip and palate
(Bmp), and fibroblast growth factors (Fgf) – are
essential in normal palatal development18. For example,
expression of Shh in the palatal epithelium is regulated
by Bmp4 in the mesenchyme. Shh then regulates Bmp2
in the mesenchyme, which is essential for mesenchymal
proliferation19,20. A positive feedback loop also exists
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between the fibroblast growth factor Fgf10 and Shh
expression in the palatal mesenchyme and epithelium,
respectively19,21. Also, the homeobox gene Msx1 further
modulates the expression of the genes Bmp4, Shh, and
Bmp2 above. At week 12, development of the palate
is completed in humans.
Genetic Analysis of Cleft Lip and Palate
Almost 500 syndromes have been identified in
syndromic cleft lip and palate22, although not all have
been linked to specific genes. Cohen23 published a
review of 154 of these syndromes with their clinical
features to aid diagnosis. However, recent molecular
genetic analysis has identified the loci of these mutations
and functions of  the implicated genes. For example,
popliteal pterygium and Van der Woude syndromes,
the latter being the most common cause of syndromic
cleft lip and palate24, are both autosomal dominant
conditions secondary to mutations in the interferon
regulatory factor-6 (Irf6) gene on chromosome 1q3225.
Interestingly, mutations in Irf6 have also been found in
non-syndromic cleft lip and palate26. The protein
product IRF6 is now known to be a transcription
factor up-regulated by TGFb3 protein in palatal fusion
during embryonic development in humans27. In
syndromic cleft lip and palate, a given gene may be
affected by several different mutations, which accounts
for the varied phenotypes that may be observed4. For
instance, mutations of  the C-terminus of  the protein
TP63 results in cleft lip or cleft palate, whereas
mutations of  the conserved DNA binding region at
the N-terminus results in cleft lip and palate8.
We conducted a search on the Online Mendelian
Inheritance in Man (OMIM) database with keywords
‘cleft lip’ and ‘cleft palate’ which produced over 1500
results. Table 1 summarizes genes implicated in some
syndromic cleft lip and palate.
Detection of genes in non-syndromic cleft lip and
palate (summarized in Table 2) has been done in recent
decades by various methods including linkage analysis,
candidate gene approach, and genome-wide
association studies (GWAS), with the discovery of
shared genetic lesions between syndromic and non-
syndromic cleft lip and palate70.
CONCLUSION
There has been some success in elucidating the genetic
basis of cleft lip and palate with the identification of
numerous susceptibility genes. However, this number
is bound to increase, revealing the overall genetic
complexity of  craniofacial clefts. Given the role of
environmental factors, studies that further explore feto-
maternal genetics together with exposure to different
environmental factors could aid in the development
of a weighted genetic risk assessment for cleft lip and
palate which in turn would better inform genetic
counselling and prescription of  preventive measures.
REFERENCES
1. Basha M, Benedicte D, Revencu N, et al. Whole
exome sequencing identifies mutations in 10% of
familial non-sydromic cleft lip and/or palate in
genes mutated in well-known syndromes. J Med
Genet. 2018;55(7):449–458.
2. Fraser F. The Genetics of  Cleft Lip and Cleft
Palate. Am J Hum Genet. 1970;22(3):336–352.
3. Wyszynski DF, Beaty TH, Maestri NE. Genetics
of Nonsyndromic Oral Clefts Revisited. Cleft
Palate-Craniofacial J. 1996;33(5):406–417.
4. Kohli SS, Kohli VS. A comprehensive review of
the genetic basis of cleft lip and palate. J Oral
Maxillofac Pathol. 2012;16(1):64–72.
5. Mitchell L, Risch N. Mode of  inheritance of




Inheritance Gene Locus Function References
Orofacial
cleft 1
AD Ofc1 6p24 - 71
Orofacial
cleft 5
- Msx1 4p16 Homeobox gene controlling expression of
downstream genes, involved in patterning of




AD Irf6 1q32 As in VDW and PPS 74
Orofacial
cleft 8
- Tp63 3q28 Apoptosis. Also in establishment of enhancers
needed for expression of genes important in




- Bmp4 14q22 Encodes BMP4 which up-regulates MSX1 and
SHH for palatal fusion.
19,75,76
Table 2: Summary of  molecular genetic mechanisms in non-syndromic cleft lip and palate
                                                   Annals of Ibadan Postgraduate Medicine. Vol. 18 2020 Cleft Supplement S19
a reanalysis. Am J Hum Genet. 1992;51(2):323–
332.
6. Sivertsen A, Wilcox AJ, Skjaerven R, et al. Familial
risk of oral clefts by morphological type and
severity: population based cohort study of first
degree relatives. BMJ. 2008;336(7641):432–4.
7. Grosen D, Chevrier C, Skytthe A, et al. A cohort
study of recurrence patterns among more than
54.000 relatives of oral cleft cases in Denmark:
support for the muultifactorial threshold model
of inheritance. J Hum Genet. 2010;47(3):162–168.
8. Stanier P, Moore GE. Genetics of  cleft lip and
palate: syndromic genes contribute to the incidence
of  non-syndromic clefts. Hum Mol Genet. 2004;
13(1):73–81.
9. Shaw GM, Wasserman CR, Murray JC, Lammer
EJ. Infant TGF-Alpha Genotype, Orofacial Clefts,
and Maternal Periconceptional Multivitamin Use.
Cleft Palate-Craniofacial J. 1998;35(4):366–370.
10. Hwang SJ, Beaty TH, Panny SR, et al. Association
study of  transforming growth factor alpha (TGF
alpha) Taq1 polymorphism and oral clefts:
indication of gene-environment interaction in a
population-based sample of infants with birth
defects. Am J Epidemiol. 1995;141(7):629–636.
11. Jugessur A, Lie RT, Wilcox AJ, et al. Variants of
developmental genes (TGFA, TGFB3, and MSX1)
and their associations with orofacial clefts: A case-
parent triad analysis. Genet Epidemiol.
2003;24(3):230–239.
12. Mo R, Freer A, Zinyk D, et al. Specific and
redundant functions of Gli2 and Gli3 zinc finger
genes in skeletal patterning and development.
Development. 1997;124(1):113–123.
13. Rijli FM, Mark M, Lakkaraju S, et al. A homeotic
transformation is generated in the rostral branchial
region of the head by disruption of Hoxa-2, which
acts as a selector gene. Cell. 1993;75(7):1333–1349.
14. Sanford PL, Ormsby I, Gittenberg-de Groot
AC, et al. TGFbeta2 knockout mice have multiple
developmental defects that are non-overlapping
with other TGFbeta knockout phenotypes.
Development1. 1997;124(13):2659–2670.
15. Peters H, Neubuser A, Kratochwil K, Balling R.
Pax-9 deficient mice lack pharyngeal pouch
derivatives and teeth and exhibit craniofacial and
limb abnormalities. Genes Dev. 1998;12(17):2735–
2747.
16. Satokata I, Maas R. Msx1 deficient mice exhibit
cleft palate and abnormalities of  craniofacial and
tooth development. Nat Genet. 1994;6(4):348–
356.
17. Zhao Y, Guo YJ, Tomac A, et al. Isolated cleft
palate in mice with a targeted mutation of the
LIM homeobox gene lhx8. Proc Natl Acad Sci
USA. 1999;96(26):15002–15006.
18. Burg ML, Chai Y, Yao CA, Iii WM, Figueiredo
JC. Epidemiology, Etiology, and Treatment of
Isolated Cleft Palate. Front Physiol. 2016;7 (March)
:1–16.
19. Chai Y, Maxson R. Recent advances in craniofacial
morphogenesis. Dev Dyn. 2006;235(9):2353–2375.
20. Smith T, Lozanoff  S, Iyyanar P, Nazarali A.
Molecular signaling along the anterior-posterior
axis of early palate development. Front Physiol.
2012;3(488):1–14.
21. Zhou J, Gao Y, Lan Y, et al. Pax9 regulates a
molecular network involving Bmp4, Fdf10, Shh
signaling and the Osr2 transcription factor to
control palate morphogenesis. Development.
2013;140(23):4709–4718.
22. Venkatesh R. Syndromes and anomalies associated
with cleft. Indian J Plast Surg. 2009;42(Suppl):S51–
55.
23. Cohen M. Syndromes with cleft lip and cleft
palate. Cleft Palate J. 1978;15(4):306–328.
24. Burdick A. Genetic epidemiology and control
of  genetic expression in van der Woude syndrome.
J Craniofac Genet Dev Biol Suppl. 1986; 2: 99–
105.
25. Kondo S, Schutte B, Richardson R, et al. Mutations
in IRF6 cause Van der Woude and popliteal
pterygium syndromes. Nat Genet. 2002;32(2):219.
26. Pegelow M, Koillinen H, Magnusson M, et al.
Association and Mutation Analyses of the IRF6
Gene in Families with Nonsyndromic and
syndromic Cleft Lip and/or Cleft Palate. Cleft
Palate-Craniofacial J. 2014;51(1):49–55.
27. Ke C-Y, Xiao W-L, Chen C-M, et al. IRF6 is the
mediator of TGFB3 during regulation of the
epithelial mesenchymal transition and palatal fusion.
Sci Rep. 2015;5(12791).
28. Suzuki K, Hu D, Bustos T, et al. Mutations of
PVRL1, encoding a cell-cell adhesion molecule/
herpesvirus receptor, in cleft lip/palate-ectodermal
dysplasia. Nat Genet. 2000;25:427–430.
29. Takahashi K, Nakanishi H, Miyahara M, et al.
Nectin/PRR: An Immunoglobulin-like Cell
Adhesion Molecule Recruited to Cadherin-based
Adherens Junctions through Interaction with
Afadin, a PDZ Domain-containing Protein. J Cell
Biol. 1999;145(3):539–549.
30. Sozen M, Suzuki K, Tolarova M, et al. Mutation
of PVRL 1 is associated with sporadic, non-
syndromic celft lilp/palate in northern Venezuela.
Nat Genet. 2001;29:141–142.
31. Palagano E, Zuccarini G, Prontera P, et al.
Mutations in the Neuroblastoma Amplified
Sequence gene in a family affected by
Acrofrontofacionasal Dysostosis type 1. Bone.
2018;114:125–136.
                                                   Annals of Ibadan Postgraduate Medicine. Vol. 18 2020 Cleft Supplement S20
32. Flores E, Tsai K, Crowley D, et al. p63 and p73
are required for p53-dependent apoptosis in
response to DNA damage. Nature. 2002; 416
(6880):560–564.
33. Kantaputra P, Hamada T, Kumchai T, McGrath
J. Heterozygous mutation in the SAM domain of
p63 undrelies Rapp-Hodgkin ectodermal
dysplasia. J Dent Res. 2003;82(6):433–437.
34. Lin-shiao E, Lan Y, Welzenbach J, et al. p63
establishes epithelial enhancers at critical cranio-
facial development genes. Sci Adv. 2019;5:1–16.
35. Gordillo M, Vega H, Trainer A, et al. The
molecular mechanism underlying Roberts
syndrome involves loss of ESCO2 acetyltrans-
ferase activity. Hum Mol Genet. 2008; 17(14):
2172–2180.
36. Vega H, Waisfisz Q, Gordillo M, et al. Roberts
syndrome is caused by mutations in ESCO2, a
human homolog of yeast ECO1 that is essential
for the establishment of sister chromatid cohesion.
Nat Genet. 2005;37:468–470.
37. McGrath J, Duijf  P, Dietsch V, et al. Hay-Wells
syndrome is caused by heterozygous missense
mutations in the SAM domain of p63. Hum Mol
Genet. 2001;10(3):221–229.
38. Ghoumid J, Stuchelcout M, Jourdain AS, et al.
Blepharocheilodontic syndrome is a CDH1
pathway-related disorder due to mutations in
CDH1 and CTNND1. Genet Med. 2017; 19:
1013–1021.
39. Riethmacher D, Brinkmann V, Birchmeier C. A
targeted mutation in the mouse E-cadherin gene
results in defective. Proc Natl Acad Sci USA. 1995;
92(3): 855–859.
40. Shamseldin H, Rajab A, Alhashem A, et al.
Mutations in DDX59 Implicate RNA Helicase in
the Pathogenesis of Orofaciodigital Syndrome.
Am J Hum Genet. 2013;93(3):555–560.
41. Basu S, Totty N, Irwin M et al. Akt phosphorylates
the Yes-associated protein, YAP, to induce
interaction with 14-3-3 and attenuation of p73-
mediated apoptosis. Mol Cell. 2003;11(1):11–23.
42. Williamson K,  Rainger J, Floyd J, et al.
Heterozygous loss-of-function mutations in YAP1
cause both isolated and syndromic optic fissure
closure defects. Am J Hum Genet. 2014; 94(2):
295–302.
43. Lopez E, Thauvin-Robinet C, Reversade B, et al.
C5orf42 is the major gene responsible for OFD
syndrome type VI. Hum Genet. 2014;133:367–
377.
44. Toriyama M, Lee C, Taylor S, et al. The ciliopathy-
associated CPLANE proteins direct basal body
recruitment of  intraflagellar transport machinery.
Nat Genet. 2016;48(6):648–656.
45. Capdevila J, Tsukui T, Esteban C, et al. Control
of  Vertebrate Limb Outgrowth by the Proximal
Factor Meis2 and Distal Antagonism of BMPs
by Gremlin. Mol Cell. 1999;4:839–849.
46. Johansson S,  Berland S, Gradek G, et al.
Haploinsufficiency of MEIS2 is associated with
orofacial clefting and learning disability. Am J Med
Genet. 2014;164(7):1622–1626.
47. Cullup T, Kho A, Dionisi-Vici C, et al. Recessive
mutations in EPG5 cause Vici syndrome, a
multisystem disorder with defective autophagy.
Nat Genet. 2014;45(1):83–87.
48. Celli J, Duijf  P, Hamel B, et al. Heterozygous
germline mutations in the p53 homolog p63 are
the cause of EEC syndrome. Cell1. 1999;99:143–
153.
49. Milunsky J, Maher T, Zhao G, et al. TFAP2A
Mutations Result in Branchio-Oculo-Facial
Syndrome. Am J Hum Genet. 2008; 82: 1171–
1177.
50. Reiber J, Sznajer Y, Posteguillo E, et al. Additional
clinical and molecular analyses of  TFAP2A in
patients with the branchio-oculo-facial syndrome.
Am J Med Genet. 2010;152(4):994–999.
51. Zarelli V, Dawid I. Inhibition of  neural crest
formation by Kctd15 involves regulation of
transcription factor AP-2. Proc Natl Acad Sci U
S A. 2013;110(8): 2870–2875.
52. Andreou A, Pauws E, Jones M, et al. TBX22
Missense Mutations Found in Patients with X-
Linked Cleft Palate Affect DNA Binding,
sumoylation, and Transcriptional Repression. Am
J Hum Genet. 2007;81:700–712.
53. Braybrook C, Doudney K, Marcano ACB, et al.
The T-box transcription factor gene TBX22 is
mutated in X-linked cleft palate and ankyloglossia.
Nat Genet. 2001;29(2):107–109.
54. Jeong Y, Leskow F, El-Jaick K, et al. Regulation
of a remote Shh forebrain enhancer by the Six3
homeoprotein. 2Nature Genet. 2008;40(11):1348–
1353.
55. Wallis D, Roessler E, Hehr U, et al. Mutations in
the homeodomain of the human SIX3 gene cause
holoprosencephaly. Nat Genet. 1999;22:196–198.
56. Kruszka P, Li D, Harr M, et al. Mutations in
SPECC1L, encoding sperm antigen with calponin
homology and coiled-coil domains 1-like, are
found in some cases of autosomal dominant
Opitz G/BBB syndrome. J Med Genet.
2015;52(2):104–110.
57. Saadi I, Alkuraya F, Gisselbrecht S, Goessling W,
Cavallesco R, Maas R. Deficiency of the
cytoskeletal protein SPECC1L leads to oblique
facial clefting. Am J Hum Genet. 2011;89(1):44–
55.
                                                   Annals of Ibadan Postgraduate Medicine. Vol. 18 2020 Cleft Supplement S21
58. Filmus J, Capurro M, Rast J. Glypicans. Genome
Biol. 2008;9(5):224.
59. Pilia G, Hughes-Benzie R, MacKenzie A, et al.
Mutations in GPC3, a glypican gene cause the
Simpson-Golabi-Behmel overgrowth syndrome.
Nat Genet. 1996;12:241–247.
60. Emes R, Ponting C. A new sequence motif  linking
lissencephaly, Treacher Collins and oral-facial-digital
type 1 syndromes, microtubule dynamics and cell
migration. Hum Mol Genet. 2001;10(24):2813–
2820.
61. Rakkolainen A, Ala-Mello S, Kristo P, Orpana
A, Jarvela I. Four novel mutations in the OFD1
(Cxorf5) gene in Finnish patients with oral-facial-
digital syndrome 1. J Med Genet. 2002;39(4):292–
296.
62. Fan Z, Li J, Zhang H, et al. A missense mutation
in PTCH2 underlies dominantly inherited NBCCS
in a Chinese family. J Med Genet. 2008;45(5):303–
308.
63. Johnson R, Rothman A, Xie J, et al. Human
homolog of patched, a candidate gene for the
basal cell nevus syndrome. Science (80-). 1996; 272
(5268):1668–1671.
64. Pastorino L,  Ghiorzo P, Nasti S, et al.
Identification of  a SUFU germline mutation in a
family with Gorlin syndrome. Am J Med Genet.
2009; 149 (7):1539–1543.
65. Ridgeway A, Skerjanc I. Pax3 is essential for
skeletal myogenesis and the expression of Six1
and Eya2. J Biol Chem. 2001;276:19033–19039.
66. Tassabehji M,  Read A, Newton V, et al.
Waardenburg’s syndrome patients have mutations
in the human homologue of the Pax-3 paured
box gene. Nature. 1992;355:635–636.
67. Vissers L, van Ravenswaaij C, Admiraal R, et al.
Mutations in a new member of the chromo-
domain gene family cause CHARGE syndrome.
Nat Genet. 2004;36:955–957.
68. Bajpai R, Chen D, Rada-Iglesias A, et al. CHD7
cooperates with PBAF to control multipotent
neural crest formation. Nature. 2010; 463 (7283):
958–962.
69. Chen L, Fulcoli F, Ferrentino R, et al.
Transcriptional control in cardiac progenitors:
Tbx1 interacts with the BAF chromatin
remodeling complex and regulates Wnt5a. PLOS
Genet. 2012;8(3):e1002571.
70. Leslie EJ, Marazita ML. Genetics of Cleft Lip
and Cleft Palate. Am J Med Genet C Semin Med
Genet. 2013;163(4):246–258.
71. Davies S, Wise C, Venkatesh B, et al. Mapping of
three translocation breakpoints associated with
orofacial clefting within 6p24 and identification
of new transcripts within the region. Cytogenet
Genome Res. 2004;105:47–53.
72. Deepak C, Ramanathan A. Role of MSX1 Gene
in Orofacial Clefting: A Systematic Review.
Biomed Pharmacol J. 2017;10(3):1071–1072.
73. van den Boogard M, Dorland M, Beemer F, van
Amstel H. MSX1 mutation is associated with
orofacial clefting and tooth agenesis in humans.
Nat Genet. 2000;24:342–343.
74. Blanton S, Cortez A, Stal S, et al. Variation in
IRF6 contributes to nonsyndromic cleft lip and
palate. Am J Med Genet. 2005;137(3):259–262.
75. Suzuki S, Marazita M, Cooper M, et al. Mutations
in BMP4 are associated with subepithelial,
microform, and overt cleft lip. Am J Hum Genet.
2009;84(3):406–411.
76. Tucker A, Matthews K, Sharpe P. Transformation
of  Tooth Type Induced by Inhibition of  BMP
Signaling. Science (80). 1998; 282(5391): 1136–
1138.
